.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The ROLARR randomized clinical trial compared robotic-assisted and conventional laparoscopic surgery for rectal cancer, focusing on an outcome of major practical importance: conversion to open laparotomy. The hypothesis was that robotic technology, with enhanced visualization and instrument dexterity, might make difficult pelvic surgery easier and reduce the need for conversion. Across the trial population, the robotic approach did not demonstrate a statistically significant overall reduction in conversion to open surgery. The result is important because adoption of robotics is often justified by technical advantages that are intuitively appealing but must still translate into clinically meaningful patient outcomes. For surgeons, ROLARR highlights a useful principle: technology should be assessed on the outcomes it changes, not only on what it can do technically. Robotics may still offer advantages in ergonomics, instrument articulation and operating in confined pelvic spaces, and the value may differ according to surgeon experience, anatomy and case complexity. The trial therefore does not make robotic surgery irrelevant; rather, it encourages a more selective and evidence-based approach. For rectal cancer programs, choice of platform should remain connected to oncological quality, surgeon expertise, patient factors, resource availability and the wider multidisciplinary pathway.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The ROLARR randomized clinical trial compared robotic-assisted and conventional laparoscopic surgery for rectal cancer, focusing on an outcome of major practical importance: conversion to open laparotomy. The hypothesis was that robotic technology, with enhanced visualization and instrument dexterity, might make difficult pelvic surgery easier and reduce the need for conversion. Across the trial population, the robotic approach did not demonstrate a statistically significant overall reduction in conversion to open surgery. The result is important because adoption of robotics is often justified by technical advantages that are intuitively appealing but must still translate into clinically meaningful patient outcomes. For surgeons, ROLARR highlights a useful principle: technology should be assessed on the outcomes it changes, not only on what it can do technically. Robotics may still offer advantages in ergonomics, instrument articulation and operating in confined pelvic spaces, and the value may differ according to surgeon experience, anatomy and case complexity. The trial therefore does not make robotic surgery irrelevant; rather, it encourages a more selective and evidence-based approach. For rectal cancer programs, choice of platform should remain connected to oncological quality, surgeon expertise, patient factors, resource availability and the wider multidisciplinary pathway.
Yesterday
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
